Multiplicity of the tumor-directed immune response. Implications for immunotherapy.
The host may generate several different types of immune response to a tumor. Some of these responses are advantageous to the host; others are not. There is evidence that several tumor-associated antigens, perhaps stimulating different facets of the immune response, are expressed by the tumor cell. We discuss the implications of this concept for immunotherapy.
D000917:Antibody Formation; D000951:Antigens, Neoplasm; D000961:Antilymphocyte Serum; D006801:Humans; D007109:Immunity; D007111:Immunity, Cellular; D007167:Immunotherapy; D008214:Lymphocytes / Q000276:immunology; D009369:Neoplasms / Q000276:immunology* / Q000628:therapy
D000951:Antigens, Neoplasm; D000961:Antilymphocyte Serum